IL98349A - Diphylase lipopeptide - Google Patents
Diphylase lipopeptideInfo
- Publication number
- IL98349A IL98349A IL9834991A IL9834991A IL98349A IL 98349 A IL98349 A IL 98349A IL 9834991 A IL9834991 A IL 9834991A IL 9834991 A IL9834991 A IL 9834991A IL 98349 A IL98349 A IL 98349A
- Authority
- IL
- Israel
- Prior art keywords
- deacylase
- kcl
- ala
- activity
- gly
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/814—Enzyme separation or purification
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/814—Enzyme separation or purification
- Y10S435/815—Enzyme separation or purification by sorption
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Enzymes And Modification Thereof (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Prostheses (AREA)
- External Artificial Organs (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53439490A | 1990-06-07 | 1990-06-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL98349A0 IL98349A0 (en) | 1992-07-15 |
IL98349A true IL98349A (en) | 1995-05-26 |
Family
ID=24129856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9834991A IL98349A (en) | 1990-06-07 | 1991-06-03 | Diphylase lipopeptide |
Country Status (14)
Country | Link |
---|---|
US (1) | US5573936A (es) |
EP (1) | EP0460882B1 (es) |
JP (1) | JP2994486B2 (es) |
KR (1) | KR0169994B1 (es) |
AT (1) | ATE140728T1 (es) |
CA (1) | CA2043762C (es) |
DE (1) | DE69121018T2 (es) |
DK (1) | DK0460882T3 (es) |
ES (1) | ES2089133T3 (es) |
GR (1) | GR3021292T3 (es) |
HU (1) | HU215232B (es) |
IE (1) | IE75885B1 (es) |
IL (1) | IL98349A (es) |
TW (1) | TW197471B (es) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6743777B1 (en) | 1992-03-19 | 2004-06-01 | Eli Lilly And Company | Cyclic peptide antifungal agents and process for preparation thereof |
EP1854877B1 (en) * | 1996-03-08 | 2012-02-08 | Astellas Pharma Inc. | Process for the deacylation of cyclic lipopeptides |
WO1997047738A1 (fr) * | 1996-06-13 | 1997-12-18 | Fujisawa Pharmaceutical Co., Ltd. | Acylase des lipopeptides cycliques |
US6153410A (en) * | 1997-03-25 | 2000-11-28 | California Institute Of Technology | Recombination of polynucleotide sequences using random or defined primers |
US6361988B1 (en) | 1997-03-25 | 2002-03-26 | California Institute Of Technology | ECB deacylase mutants |
US5936074A (en) * | 1997-04-17 | 1999-08-10 | Eli Lilly And Company | Teicoplanin deacylation process and product |
US6323176B1 (en) | 1998-02-25 | 2001-11-27 | Eli Lilly And Company | Cyclic peptide antifungal agents |
EP1137663B1 (en) | 1998-12-09 | 2006-08-30 | Eli Lilly And Company | Purification of echinocandin cyclopeptide compounds |
DE60019902D1 (de) | 1999-03-03 | 2005-06-09 | Lilly Co Eli | Echinocandin pharmazeutische zusammensetzungen |
JP2002538097A (ja) | 1999-03-03 | 2002-11-12 | イーライ リリー アンド カンパニー | 薬学的経口ecb処方物および組成物の作製方法 |
PT1157030E (pt) | 1999-03-03 | 2004-01-30 | Lilly Co Eli | Complexos equinocandina/hidrato de carbono |
CA2362826A1 (en) | 1999-03-03 | 2000-09-08 | Michael Anthony Dotlich | Formation and anion-exchange of crystalline echinocandin ammonium salts |
CN1361791A (zh) * | 1999-07-15 | 2002-07-31 | 伊莱利利公司 | 脂缩肽脱酰方法 |
CA2394350A1 (en) * | 1999-12-15 | 2001-06-21 | Cubist Pharmaceuticals, Inc. | Lipopeptides as antibacterial agents |
BR0017028A (pt) * | 1999-12-15 | 2003-01-07 | Cubist Pharm Inc | Lipopepìdeos como agentes antibacterianos |
US6911525B2 (en) * | 1999-12-15 | 2005-06-28 | Cubist Pharmaceuticals, Inc. | Lipopeptides as antibacterial agents |
US6696412B1 (en) | 2000-01-20 | 2004-02-24 | Cubist Pharmaceuticals, Inc. | High purity lipopeptides, Lipopeptide micelles and processes for preparing same |
US20060014674A1 (en) | 2000-12-18 | 2006-01-19 | Dennis Keith | Methods for preparing purified lipopeptides |
EP1423137B1 (en) * | 2001-08-06 | 2009-04-29 | Cubist Pharmaceuticals, Inc. | Lipopeptide stereoisomers, methods for preparing same, and useful intermediates |
US6991800B2 (en) | 2002-06-13 | 2006-01-31 | Vicuron Pharmaceuticals Inc. | Antifungal parenteral products |
DE102004060750A1 (de) | 2004-12-15 | 2006-07-13 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Deacylierung von Lipopeptiden |
BRPI0923567A2 (pt) * | 2008-12-22 | 2016-09-27 | Cubist Pharm Inc | agentes antibactericidas novos para o tratamento de infecções gram positivas |
US9394340B2 (en) * | 2009-03-24 | 2016-07-19 | Cadila Healthcare Limited | Purification process for lipopeptides |
US20150218221A1 (en) | 2012-09-24 | 2015-08-06 | Dsm Sinochem Pharmaceuticals Netherlands B.V. | Method for producing a cyclic peptide |
KR101425108B1 (ko) * | 2012-09-25 | 2014-07-31 | 동국제약 주식회사 | 탈아실화된 환상 리포펩티드의 제조방법 |
CN108410929B (zh) * | 2018-05-30 | 2024-01-26 | 博瑞生物医药(苏州)股份有限公司 | 阿尼芬净前体的制备方法 |
CN109593809A (zh) * | 2018-12-07 | 2019-04-09 | 成都雅途生物技术有限公司 | 一种固定化微生物酶转化棘白菌素b的方法 |
CN113215185B (zh) * | 2021-04-22 | 2022-04-29 | 浙江工业大学 | 一种用于重组表达棘白菌素b脱酰基酶的重组基因序列 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1159450A (en) * | 1979-12-13 | 1983-12-27 | Manuel Debono | Process for the preparation of derivatives of cyclic peptide nuclei |
-
1991
- 1991-06-03 DE DE69121018T patent/DE69121018T2/de not_active Expired - Fee Related
- 1991-06-03 ES ES91304976T patent/ES2089133T3/es not_active Expired - Lifetime
- 1991-06-03 EP EP91304976A patent/EP0460882B1/en not_active Expired - Lifetime
- 1991-06-03 IL IL9834991A patent/IL98349A/en not_active IP Right Cessation
- 1991-06-03 CA CA002043762A patent/CA2043762C/en not_active Expired - Fee Related
- 1991-06-03 DK DK91304976.3T patent/DK0460882T3/da active
- 1991-06-03 AT AT91304976T patent/ATE140728T1/de not_active IP Right Cessation
- 1991-06-04 JP JP3132622A patent/JP2994486B2/ja not_active Expired - Fee Related
- 1991-06-05 KR KR1019910009280A patent/KR0169994B1/ko not_active IP Right Cessation
- 1991-06-06 IE IE193991A patent/IE75885B1/en not_active IP Right Cessation
- 1991-06-06 TW TW080104442A patent/TW197471B/zh active
- 1991-06-06 HU HU911897A patent/HU215232B/hu not_active IP Right Cessation
-
1995
- 1995-05-18 US US08/444,126 patent/US5573936A/en not_active Expired - Fee Related
-
1996
- 1996-10-09 GR GR960402663T patent/GR3021292T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
KR0169994B1 (ko) | 1999-02-01 |
IE75885B1 (en) | 1997-09-24 |
EP0460882A3 (en) | 1992-04-22 |
EP0460882A2 (en) | 1991-12-11 |
CA2043762C (en) | 2001-05-29 |
ATE140728T1 (de) | 1996-08-15 |
DK0460882T3 (da) | 1996-08-26 |
IL98349A0 (en) | 1992-07-15 |
CA2043762A1 (en) | 1991-12-08 |
DE69121018D1 (de) | 1996-08-29 |
US5573936A (en) | 1996-11-12 |
GR3021292T3 (en) | 1997-01-31 |
IE911939A1 (en) | 1991-12-18 |
TW197471B (es) | 1993-01-01 |
ES2089133T3 (es) | 1996-10-01 |
KR920000919A (ko) | 1992-01-29 |
HU215232B (hu) | 1998-11-30 |
DE69121018T2 (de) | 1996-12-19 |
HUT61587A (en) | 1993-01-28 |
JPH04228072A (ja) | 1992-08-18 |
EP0460882B1 (en) | 1996-07-24 |
JP2994486B2 (ja) | 1999-12-27 |
HU911897D0 (en) | 1991-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0460882B1 (en) | Lipopeptide deacylase | |
US4948874A (en) | Purified protein G from streptococcal bacteria | |
Stern et al. | Opioid hexapeptides and heptapeptides in adrenal medulla and brain possible implications on the biosynthesis of enkephalins | |
Otani et al. | Purification and primary structure of C-1027-AG, a selective antagonist of antitumor antibiotic C-1027, from Streptomyces globisporus | |
CA1146468A (en) | Homogeneous fibroblast interferon and method for manufacture thereof | |
US5095092A (en) | Process for the isolation and purification of hirudin | |
Alouf et al. | Purification and some properties of streptolysin O | |
CA1338415C (en) | C-terminal amidating enzyme composition, process for preparing, and use of the same | |
Grant et al. | Rat liver prothrombin precursors: purification of a second, more basic form | |
McMaster et al. | The growth-associated neuronal phosphoprotein B-50: improved purification, partial primary structure, and characterization and localization of proteolysis products | |
Kramer et al. | [35] Assay and purification of phospholipase A2 from human synovial fluid in rheumatoid arthritis | |
AU618035B2 (en) | A method for the selective cleavage of fusion proteins | |
Pacaud | Purification of protease II from Escherichia coli by affinity chromatography and separation of two enzyme species from cells harvested at late log phase | |
Ryu et al. | Semisynthetic β-lactam antibiotics synthesizing enzyme from Acetobacter turbidans: purification and properties | |
CA1301098C (en) | Purified enzyme and process therefor | |
GB2083477A (en) | Endoproteinase-lys-c and process for the preparation thereof | |
Takeuchi et al. | Purification of human lung angiotensin-converting enzyme by high-performance liquid chromatography: Properties and N-terminal amino acid sequence | |
EP0337430B1 (en) | Antitumor antibiotic kedarcidin | |
Meng et al. | Preparative isolation of angiotensin-converting enzyme from human lung | |
Diedrich et al. | Apparent extracellular glycoprotein turnover product from Candida albicans | |
Kempe et al. | Enzymatic synthesis of dipeptide units of the d‐d‐configuration in aqueous media | |
Yuuki et al. | Purification and some properties of two enzymes from a β-glucanase hyperproducing strain, Bacillus subtilis HL-25 | |
Kato et al. | A rapid and simple method for the isolation of S100a0 (αα) protein by high-performance liquid chromatography | |
EP0403172A2 (en) | Purified enzyme and process therefor | |
JP2551399B2 (ja) | C末端アミド化に関与する酵素並びにその製造方法及びその使用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |